Small Cardioactive Peptide B (SCPB), a neurally active peptide, stimulates adenylate cyclase activity in particulate fractions of both heart and gill tissues with EC50s of 0.1 and 1.0 μM, respectively.
Small Cardioactive Peptide B SCPB is a bioactive peptide recognized for its modulatory roles in invertebrate neurobiology, particularly within cardiac and neuromuscular systems. As a member of the small cardioactive peptide family, SCPB is characterized by its conserved sequence motifs and its ability to influence physiological processes through receptor-mediated signaling. Its functional significance is underscored by its capacity to modulate heart rate, muscle contraction, and neurotransmission in various model organisms, making it a valuable tool for researchers investigating the molecular mechanisms underlying peptide-mediated regulation of physiological functions.
Neurophysiology research: SCPB is widely utilized in studies aimed at elucidating the mechanisms of neuropeptide signaling in invertebrate nervous systems. Through its interaction with specific G protein-coupled receptors, it serves as a model compound for dissecting the pathways involved in synaptic modulation and neuronal communication. Researchers employ SCPB to investigate how neuropeptides influence ion channel activity, synaptic plasticity, and overall neural circuit dynamics, providing critical insights into the broader field of neurobiology.
Cardiac modulation studies: The peptide is instrumental in exploring the regulation of cardiac function, particularly in crustaceans and mollusks. By applying SCPB to isolated heart preparations or in vivo models, scientists can directly observe its chronotropic and inotropic effects on cardiac tissues. These studies help clarify the molecular underpinnings of heart rate control and contractility, contributing to a deeper understanding of how endogenous peptides influence cardiovascular physiology in non-mammalian systems.
Peptide-receptor interaction assays: SCPB is frequently used in binding and functional assays to characterize the pharmacological properties of its cognate receptors. By utilizing radiolabeled or fluorescently tagged forms of the peptide, researchers can quantify receptor affinity, map binding sites, and assess downstream signaling events. These assays are essential for identifying receptor subtypes, understanding ligand specificity, and developing novel tools for modulating neuropeptide pathways.
Comparative physiology investigations: The evolutionary conservation and diversity of small cardioactive peptides make SCPB a valuable reagent for cross-species analyses. Scientists employ the peptide to compare its functional effects across different invertebrate taxa, thereby uncovering conserved mechanisms and species-specific adaptations in peptide signaling. Such comparative studies enhance our understanding of the evolution of neuropeptidergic regulation and the functional diversification of peptide families.
Peptide structure-function analysis: SCPB also serves as a reference compound in studies aimed at elucidating the relationship between peptide sequence, conformation, and biological activity. By synthesizing analogs or performing site-directed mutagenesis, researchers can systematically assess the structural determinants required for receptor activation and physiological response. These investigations not only inform the design of novel peptide-based probes but also advance fundamental knowledge of peptide-receptor interactions and signal transduction mechanisms.
If you have any peptide synthesis requirement in mind, please do not hesitate to contact us at . We will endeavor to provide highly satisfying products and services.
Creative Peptides is a trusted CDMO partner specializing in high-quality peptide synthesis, conjugation, and manufacturing under strict cGMP compliance. With advanced technology platforms and a team of experienced scientists, we deliver tailored peptide solutions to support drug discovery, clinical development, and cosmetic innovation worldwide.
From custom peptide synthesis to complex peptide-drug conjugates, we provide flexible, end-to-end services designed to accelerate timelines and ensure regulatory excellence. Our commitment to quality, reliability, and innovation has made us a preferred partner across the pharmaceutical, biotechnology, and personal care industries.